Sanofi Management
Management criteria checks 3/4
Sanofi's CEO is Paul Hudson, appointed in Sep 2019, has a tenure of 4.33 years. total yearly compensation is €10.72M, comprised of 13.1% salary and 86.9% bonuses, including company stock and options. directly owns 0% of the company’s shares, worth MX$9.67M. The average tenure of the management team and the board of directors is 4.8 years and 4.6 years respectively.
Key information
Paul Hudson
Chief executive officer
€10.7m
Total compensation
CEO salary percentage | 13.1% |
CEO tenure | 4.3yrs |
CEO ownership | 0.0004% |
Management average tenure | 4.8yrs |
Board average tenure | 4.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | €9b |
Jun 30 2023 | n/a | n/a | €9b |
Mar 31 2023 | n/a | n/a | €8b |
Dec 31 2022 | €11m | €1m | €8b |
Sep 30 2022 | n/a | n/a | €6b |
Jun 30 2022 | n/a | n/a | €7b |
Mar 31 2022 | n/a | n/a | €7b |
Dec 31 2021 | €11m | €1m | €6b |
Sep 30 2021 | n/a | n/a | €6b |
Jun 30 2021 | n/a | n/a | €6b |
Mar 31 2021 | n/a | n/a | €12b |
Dec 31 2020 | €11m | €1m | €12b |
Sep 30 2020 | n/a | n/a | €11b |
Jun 30 2020 | n/a | n/a | €11b |
Mar 31 2020 | n/a | n/a | €3b |
Dec 31 2019 | €6m | €433k | €3b |
Compensation vs Market: Paul's total compensation ($USD11.64M) is above average for companies of similar size in the MX market ($USD5.77M).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
CEO
Paul Hudson (56 yo)
4.3yrs
Tenure
€10,718,747
Compensation
Mr. Paul Hudson serves as Chief Executive Officer of Sanofi at Hoechst Pakistan Limited (formerly known as sanofi-aventis Pakistan Limited). He has been Chief Executive Officer at Sanofi since September 1,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 4.3yrs | €10.72m | 0.00045% € 9.7m | |
Executive VP & CFO | 5.3yrs | no data | no data | |
Executive VP & Head of Business Operations | less than a year | no data | no data | |
Principal Accounting Officer and Vice President of Corporate Accounting | no data | no data | no data | |
Chief Science Officer of Consumer Health Care | no data | no data | no data | |
Head of Investor Relations | no data | no data | no data | |
Global Compliance Officer & VP | 11.8yrs | no data | no data | |
Executive VP & General Counsel | 1.9yrs | no data | no data | |
Head of Communications | no data | no data | no data | |
Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing | 19.4yrs | no data | no data | |
Executive VP & Chief People Officer | 3.4yrs | no data | no data | |
Senior Vice President of Audit & Internal Control Assessment | 21.7yrs | no data | no data |
4.8yrs
Average Tenure
57yo
Average Age
Experienced Management: SAN1 N's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 4.3yrs | €10.72m | 0.00045% € 9.7m | |
Honorary Chairman | 13.7yrs | €4.71m | no data | |
Honorary Chairman | less than a year | €807.74k | 0.00013% € 2.8m | |
Independent Director | 9.7yrs | €164.75k | 0.000080% € 1.7m | |
Independent Director | 3.8yrs | €170.25k | 0.000080% € 1.7m | |
Independent Chairman | less than a year | €37.50k | 0.000040% € 859.8k | |
Independent Director | 10.7yrs | €173.00k | 0.000080% € 1.7m | |
Independent Director | 2.1yrs | €184.00k | 0.000080% € 1.7m | |
Independent Director | 7.7yrs | €236.25k | 0.00010% € 2.1m | |
Independent Director | 7.7yrs | €233.50k | 0.00010% € 2.1m | |
Independent Director | 3.8yrs | €145.50k | 0.000080% € 1.7m | |
Director | 4.9yrs | €159.25k | 0.000080% € 1.7m |
4.6yrs
Average Tenure
63.5yo
Average Age
Experienced Board: SAN1 N's board of directors are considered experienced (4.6 years average tenure).